3',4'-Dimethoxy-2,2,2-trifluoroacetophenone, 97.0%, 5g

2-Chloro-9-methyl-7H-purin-8(9H)-one, 95.0%, 250mg

(2R,3S,4R)-2-(Hydroxymethyl)-5-methoxytetrahydrofuran-3,4-diol, 95.0%, 100g

(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-Bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol, 98%, 100mg

6-Chloropyridine-2-sulfonamide, 98%, 250mg

2-(4-(Benzyloxy)-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 1g

1-(3-Fluoro-2-nitrophenyl)piperidin-4-ol, 95.0%, 1g

Agitador magnético serie C-MAG MS, 5 l, C-MAG MS 4, 1 pieza

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid, 98%, 100mg

Methyl 3-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylate, 95%, 250mg

2-Amino-2-(3,4-dichlorophenyl)acetonitrile, 97%, 1g

5-FLUORO-3-NITRO-4'-(TRIFLUOROMETHYL)-[1,1'-BIPHENYL]-2-AMINE, 90.0%, 250mg

Ethyl 2-ethyl-4-methyl-3-oxopentanoate, 95%, 250mg